Vir Biotechnology
VIR
VIR
205 hedge funds and large institutions have $908M invested in Vir Biotechnology in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 72 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 72
4% less funds holding
Funds holding: 213 → 205 (-8)
15% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 33
Holders
205
Holding in Top 10
2
Calls
$3.64M
Puts
$2.3M
Top Buyers
| 1 | +$29.7M | |
| 2 | +$28.8M | |
| 3 | +$11M | |
| 4 |
BlackRock
New York
|
+$10.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.42M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$10.6M | |
| 3 | -$6.64M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$6.14M |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$4.21M |